Leone Patterson
Director of Finance/CFO chez TENAYA THERAPEUTICS, INC.
Fortune : 532 403 $ au 31/03/2024
Profil
Ms. Leone D.
Patterson is an Independent Non-Executive Director at Oxford Biomedica Plc, a Chief Financial & Business Officer at Tenaya Therapeutics, Inc. and an Independent Director at Nkarta, Inc. She is on the Board of Directors at Oxford Biomedica Plc and Nkarta, Inc. Ms. Patterson was previously employed as an Independent Director by Eliem Therapeutics, Inc., a President, Chief Financial & Accounting Officer by Adverum Biotechnologies, Inc., a Chief Financial Officer by Diadexus, Inc., a Chief Financial Officer & Vice President by Pivot Acquisition, Inc., a Vice President & Global Corporate Controller by NetApp, Inc., a Vice President-Finance by Exelixis, Inc., a VP-Global Business Planning & Analysis by Novartis AG, a Vice President & Corporate Controller by Chiron Corp., and a Senior Manager by KPMG LLP.
She received her undergraduate degree from Chapman University and an MBA from St. Mary's College (Indiana).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/02/2024 | 95 755 ( 0,12% ) | 500 799 $ | 31/03/2024 | |
OXFORD BIOMEDICA PLC
0,01% | 26/09/2023 | 12 447 ( 0,01% ) | 31 605 $ | 31/03/2024 |
NKARTA, INC.
-.--% | 07/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Leone Patterson
| Sociétés | Poste | Début |
|---|---|---|
| NKARTA, INC. | Director/Board Member | 27/04/2020 |
| TENAYA THERAPEUTICS, INC. | Director of Finance/CFO | 01/06/2021 |
| OXFORD BIOMEDICA PLC | Director/Board Member | 01/05/2023 |
Anciens postes connus de Leone Patterson
| Sociétés | Poste | Fin |
|---|---|---|
| ELIEM THERAPEUTICS, INC. | Director/Board Member | 19/01/2023 |
| ADVERUM BIOTECHNOLOGIES, INC. | Chief Executive Officer | 15/06/2020 |
| DIADEXUS, INC. | Director of Finance/CFO | 01/06/2016 |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Director of Finance/CFO | 30/10/2014 |
| NETAPP, INC. | Comptroller/Controller/Auditor | 01/06/2012 |
Formation de Leone Patterson
| Chapman University | Undergraduate Degree |
| St. Mary's College (Indiana) | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 8 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| OXFORD BIOMEDICA PLC | Health Technology |
| NETAPP, INC. | Electronic Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| NKARTA, INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| ELIEM THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Health Technology |
Diadexus, Inc.
 Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
